Reappraisal of GIK in Acute STEMI by Pre-hospital Administration
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
1. to assess whether pre-hospital glucose-insulin-potassium (GIK) administration in acute
STEMI patients would reduce infarct size and ischemia/reperfusion damage using
comprehensive tissue characterization by cardiovascular magnetic resonance (CMR) at an
early post-infarction phase.
2. to explore the putative cardioprotective mechanisms of pre-hospital GIK administration